Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |